Nohla Therapeutics I
Nohla Therapeutics Initiates Global LAUNCH Phase 2 Trial of NLA101 in Patients with AML
February 13, 2018 13:00 ET | Nohla Therapeutics
SEATTLE, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a clinical stage biopharmaceutical company focused on the development of universal, off-the-shelf cell therapies to treat...
Nohla Therapeutics G
Nohla Therapeutics Granted Orphan Drug Designation in the European Union for NLA101 in the Treatment of Hematopoietic Stem Cell Transplantation
January 23, 2018 13:00 ET | Nohla Therapeutics
SEATTLE, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a clinical stage biopharmaceutical company focused on the development of universal donor, off-the-shelf cell therapies to...
Nohla Therapeutics A
Nohla Therapeutics Announces Hiring of Jim Johnson as Chief Financial Officer
January 04, 2018 16:00 ET | Nohla Therapeutics
SEATTLE, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading cell therapy company that provides a short-term bridge to long-term health for patients with critical diseases,...
Nohla Therapeutics A
Nohla Therapeutics Awarded $6.9 Million Grant from the California Institute of Regenerative Medicine to Further Develop NLA101 Cell Therapy for the Treatment of Patients with Acute Myeloid Leukemia
September 28, 2017 15:33 ET | Nohla Therapeutics
SEATTLE, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cell therapies for patients with hematologic malignances and other critical...
Nohla Therapeutics P
Nohla Therapeutics President and CEO, Katie Fanning, to Present at 2017 Life Science Innovation Northwest Conference
May 16, 2017 05:30 ET | Nohla Therapeutics
SEATTLE, May 16, 2017 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading innovator in the development of off-the-shelf universal donor cellular therapies, announced today that Katie...
Nohla Therapeutics A
Nohla Therapeutics Announces Collaboration with University of California, Davis to Optimize Manufacturing Process and Supply Cell Therapy Product for Clinical Trials
March 28, 2017 05:30 ET | Nohla Therapeutics
SEATTLE, March 28, 2017 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading innovator in the development of off-the-shelf universal donor cellular therapies, announced today the...
Nohla Therapeutics t
Nohla Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference on March 7th, 2017
February 14, 2017 05:30 ET | Nohla Therapeutics
SEATTLE, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading innovator in the development of universal donor cellular therapies for the treatment of patients with blood...
Nohla Therapeutics A
Nohla Therapeutics Appoints Kathleen Fanning as President and Chief Executive Officer
February 02, 2017 05:30 ET | Nohla Therapeutics
SEATTLE, Feb. 02, 2017 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with life threatening...
Positive Pre-Clinica
Positive Pre-Clinical and Clinical Data for Nohla Therapeutics’ Cell Product to Be Presented at the 58th ASH Annual Meeting and Exposition
December 01, 2016 05:30 ET | Nohla Therapeutics
SEATTLE, Dec. 01, 2016 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with life threatening...
Nohla Therapeutics A
Nohla Therapeutics Appoints Shelly Heimfeld, Ph.D., Executive Vice President of Research and Manufacturing
November 30, 2016 05:30 ET | Nohla Therapeutics
SEATTLE, Nov. 30, 2016 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with life threatening...